dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Calucho Prim, Maite |
dc.contributor.author | Gartner Tizzano, Silvia |
dc.contributor.author | Barranco Bartolomé, Paula |
dc.contributor.author | Fernández Álvarez, Paula |
dc.contributor.author | García Pérez, Raquel |
dc.contributor.author | Tizzano Ferrari, Eduardo Fidel |
dc.date.accessioned | 2022-03-23T12:01:15Z |
dc.date.available | 2022-03-23T12:01:15Z |
dc.date.issued | 2021-07-30 |
dc.identifier.citation | Calucho M, Gartner S, Barranco P, Fernández-Álvarez P, Pérez RG, Tizzano EF. Validation of nasospheroids to assay CFTR functionality and modulator responses in cystic fibrosis. Sci Rep. 2021 Jul 30;11:15511. |
dc.identifier.issn | 2045-2322 |
dc.identifier.uri | https://hdl.handle.net/11351/7252 |
dc.description | Fibrosi quística; Marcadors predictius; Models d'aparell respiratori |
dc.description.sponsorship | This work was supported by a grant from Fundación Mutua Madrileña (Rare disorders, MM/XIV/RECERCA/2017/TIZZANO) to E.F.T. and Fundació Arcadi to S.G. and supporting M.C. and P.B.; M.C. was partially supported by Fundació Daniel Bravo Andreu. |
dc.language.iso | eng |
dc.publisher | Nature Research |
dc.relation.ispartofseries | Scientific Reports;11 |
dc.rights | Attribution 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ |
dc.source | Scientia |
dc.subject | Fibrosi quística - Fisiologia patològica |
dc.subject | Cultiu cel·lular - Investigació |
dc.subject | Fibrosi quística - Tractament |
dc.subject.mesh | Spheroids, Cellular |
dc.subject.mesh | /metabolism |
dc.subject.mesh | Cystic Fibrosis |
dc.subject.mesh | /pathology |
dc.title | Validation of nasospheroids to assay CFTR functionality and modulator responses in cystic fibrosis |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.1038/s41598-021-94798-x |
dc.subject.decs | esferoides celulares |
dc.subject.decs | /metabolismo |
dc.subject.decs | fibrosis quística |
dc.subject.decs | /patología |
dc.relation.publishversion | https://doi.org/10.1038/s41598-021-94798-x |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Calucho M, Barranco P, Fernández-Álvarez P, Tizzano EF] Grup de Recerca en Medicina Genètica, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Servei de Genètica Clínica i Molecular, Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Gartner S] Unitat de Fibrosi Quística, Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Pérez RG] Universitat Autònoma de Barcelona, Bellaterra, Spain |
dc.identifier.pmid | 34330959 |
dc.identifier.wos | 000683318500005 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |